Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents with Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model

JACC: Cardiovascular Interventions

Volumn 8, Issue 9, 2015, Pages 1248-1260

  Otsuka, Fumiyuki ^a   Cheng, Qi ^a   Yahagi, Kazuyuki ^a   Acampado, Eduardo ^a   Sheehy, Alexander ^b   Yazdani, Saami K ^a   Sakakura, Kenichi ^a   Euller, Kristina ^a   Perkins, Laura E L ^b   Kolodgie, Frank D ^a   Virmani, Renu ^a   Joner, Michael ^a  

^a CVPATH INSTITUTE   (United States)

^b ABBOTT VASCULAR   (United States)

Author keywords

coronary disease; pathology; stents; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; BETA3 INTEGRIN; CLOPIDOGREL; EVEROLIMUS; GLYCOPROTEIN IB ALPHA; HEPARIN; POLYMER; BIOMATERIAL; CARDIOVASCULAR AGENT;

ANIMAL EXPERIMENT; ARTERIOVENOUS SHUNT; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG ELUTING CORONARY STENT; EVEROLIMUS ELUTING CORONARY STENT; EX VIVO STUDY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PIG; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOGENICITY; ACUTE DISEASE; ADVERSE EFFECTS; ANIMAL; ANIMAL MODEL; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DEVICES; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; INFLAMMATION; MATERIALS TESTING; PROSTHESIS DESIGN; THROMBOSIS; TIME FACTOR;

ACUTE DISEASE; ANIMALS; BLOOD COAGULATION; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; ENDOVASCULAR PROCEDURES; EVEROLIMUS; INFLAMMATION; MATERIALS TESTING; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; MODELS, ANIMAL; PLATELET AGGREGATION; POLYMERS; PROSTHESIS DESIGN; SWINE; THROMBOSIS; TIME FACTORS;

EID: 84939480232     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.03.029     Document Type: Article

References (31)

1. N. Kukreja, Y. Onuma, H.M. Garcia-Garcia, et al. for the Interventional Cardiologists of the Thoraxcenter (2000 to 2005) The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents J Am Coll Cardiol Intv 2 2009 534 541
2. A.T. Ong, A. Hoye, J. Aoki, and et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation J Am Coll Cardiol 45 2005 947 953
3. M. Nakano, K. Yahagi, F. Otsuka, and et al. Causes of early stent thrombosis in patients presenting with acute coronary syndrome: an ex vivo human autopsy study J Am Coll Cardiol 63 2014 2510 2520
4. K. Kolandaivelu, R. Swaminathan, W.J. Gibson, and et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
5. T. Palmerini, G. Biondi-Zoccai, D. Della Riva, and et al. Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis Lancet 379 2012 1393 1402
6. P.C. Smits, E. Kedhi, K.J. Royaards, and et al. 2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice: COMPARE (Comparison of the Everolimus Eluting XIENCE-V Stent With the Paclitaxel Eluting TAXUS LIBERTE Stent in All-Comers: A Randomized Open Label Trial) J Am Coll Cardiol 58 2011 11 18
7. M. Sabate, A. Cequier, A. Iniguez, and et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial Lancet 380 2012 1482 1490
8. A. Colombo, H. Zahedmanesh, D.M. Toner, P.A. Cahill, and C. Lally A method to develop mock arteries suitable for cell seeding and in-vitro cell culture experiments J Mech Behav Biomed Mater 3 2010 470 477
9. T. Hothorn, F. Bretz, and P. Westfall Simultaneous inference in general parametric models Biom J 50 2008 346 363
10. C.W. Dunnett A multiple comparison procedure for comparing several treatments with a control J Am Stat Assoc 50 1955 1096 1121
11. G. Schurtz, C. Delhaye, C. Hurt, H. Thieuleux, and G. Lemesle Biodegradable polymer biolimus-eluting stent (Nobori) for the treatment of coronary artery lesions: review of concept and clinical results Med Devices (Auckl) 7 2014 35 43
12. M.W. Basalus, M. Joner, C. von Birgelen, and R.A. Byrne Polymer coatings on drug-eluting stents: Samson's hair and Achilles' heel? EuroIntervention 9 2013 302 305
13. J.M. Garasic, E.R. Edelman, J.C. Squire, P. Seifert, M.S. Williams, and C. Rogers Stent and artery geometry determine intimal thickening independent of arterial injury Circulation 101 2000 812 818
14. A. Kastrati, J. Mehilli, J. Dirschinger, and et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial Circulation 103 2001 2816 2821
15. J.E. Aslan, G.W. Tormoen, C.P. Loren, J. Pang, and O.J. McCarty S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation Blood 118 2011 3129 3136
16. A.S. Weyrich, M.M. Denis, H. Schwertz, and et al. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets Blood 109 2007 1975 1983
17. J. Aoki, A.J. Lansky, R. Mehran, and et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 119 2009 687 698
18. G.D. Dangas, B.E. Claessen, R. Mehran, and et al. Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes J Am Coll Cardiol Intv 5 2012 1097 1105
19. F. Alfonso, A. Suarez, D.J. Angiolillo, and et al. Findings of intravascular ultrasound during acute stent thrombosis Heart 90 2004 1455 1459
20. S.Y. Choi, B. Witzenbichler, A. Maehara, and et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy Circ Cardiovasc Interv 4 2011 239 247
21. U. Baber, R. Mehran, S.K. Sharma, and et al. Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials J Am Coll Cardiol 58 2011 1569 1577
22. P.C. Smits, S. Hofma, M. Togni, and et al. Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial Lancet 381 2013 651 660
23. M. Natsuaki, K. Kozuma, T. Morimoto, et al. for the NEXT Investigators Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial J Am Coll Cardiol 62 2013 181 190
24. R. Virmani, F.D. Kolodgie, A. Farb, and A. Lafont Drug eluting stents: are human and animal studies comparable? Heart 89 2003 133 138
25. C. Chaabane, F. Otsuka, R. Virmani, and M.L. Bochaton-Piallat Biological responses in stented arteries Cardiovasc Res 99 2013 353 363
26. P.L. Giesen, U. Rauch, B. Bohrmann, and et al. Blood-borne tissue factor: another view of thrombosis Proc Natl Acad Sci U S A 96 1999 2311 2315
27. U. Rauch, D. Bonderman, B. Bohrmann, and et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor Blood 96 2000 170 175
28. N. Faraday, K. Schunke, S. Saleem, and et al. Cathepsin G-dependent modulation of platelet thrombus formation in vivo by blood neutrophils PLoS One 8 2013 e71447
29. A. Farb, D.K. Weber, F.D. Kolodgie, A.P. Burke, and R. Virmani Morphological predictors of restenosis after coronary stenting in humans Circulation 105 2002 2974 2980
30. F.G. Welt, E.R. Edelman, D.I. Simon, and C. Rogers Neutrophil, not macrophage, infiltration precedes neointimal thickening in balloon-injured arteries Arterioscler Thromb Vasc Biol 20 2000 2553 2558
31. J.A. Chinn, J.A. Sauter, R.E. Phillips Jr., and et al. Blood and tissue compatibility of modified polyester: thrombosis, inflammation, and healing J Biomed Mater Res 39 1998 130 140